Funded Startups in Sor-Trondelag
In Sor-Trøndelag’s 12 most recent disclosed rounds, the largest amount is CardioMech’s $13M (2024-01-02).
In Sor-Trøndelag’s 12 most recent disclosed rounds, the largest amount is CardioMech’s $13M (2024-01-02). That top figure sits only slightly above Maritime Robotics’ $12M (2024-09-12) and above the rest of the table’s disclosed amounts that largely cluster between $1M and $7M, making CardioMech a clear size outlier but not one that dwarfs the whole set.
The entries are also time-concentrated: 2024 accounts for most of the list, with five rounds between 2024-07-01 (Leasi $1M) and 2024-11-18 (Biosergen AS $4M), including three transactions in July 2024 (Versiro $3M on 2024-07-03; Leasi $1M on 2024-07-01; plus GlucoSet’s earlier 2023 baseline). Sector-wise, Biotechnology appears repeatedly (Biosergen AS 2024-11-18 $4M; CardioMech 2024-01-02 $13M), while “Series Unknown” is the dominant funding label across multiple years (including 2024-09-12, 2024-11-18, and 2023-02-20). The date window runs from 2021-10-14 (OptoScale) through 2024-11-18 (Biosergen AS).
Most recent rounds
12 shownRelated listings
Frequently asked
What stands out on deal size, and where does the largest disclosed round fall relative to the rest?
CardioMech’s $13M (2024-01-02) is the largest disclosed amount in the 12-row view, edging out Maritime Robotics’ $12M (2024-09-12). Outside those two, most disclosed rounds are in a lower band, including several at $5M (Seaweed Solutions 2023-01-16; OptoScale 2021-10-14) and $4M (Biosergen AS 2024-11-18; Nomono 2022-09-14).
Which sectors are over-represented, and how does that compare to one-off categories?
Biotechnology is the only sector that clearly repeats within this slice: Biosergen AS (2024-11-18, $4M) and CardioMech (2024-01-02, $13M). Other sectors show up once each (e.g., Agriculture and Farming: Seaweed Solutions $5M on 2023-01-16 and OptoScale $5M on 2021-10-14; Hardware: Maritime Robotics $12M on 2024-09-12 and Nomono $4M on 2022-09-14).
Is there a tight cluster in the most recent months of 2024, or are rounds spread out?
There’s a concentration in mid-to-late 2024: Versiro ($3M, 2024-07-03), Leasi ($1M, 2024-07-01), Maritime Robotics ($12M, 2024-09-12), and Biosergen AS ($4M, 2024-11-18) all fall within about four months of each other. The table’s earliest row is 2021-10-14 (OptoScale $5M), so the visible activity skews toward the right edge of the window.
Which funding-stage labels dominate this list, and what share are effectively unclassified?
“Series Unknown” is the most frequent label, appearing in multiple entries such as Biosergen AS (2024-11-18, $4M), Maritime Robotics (2024-09-12, $12M), and Zeabuz (2023-02-20, $2M). Named stages that recur are less common in this slice: Seed appears for Versiro (2024-07-03, $3M), Seaweed Solutions (2023-01-16, $5M), and Nomono (2022-09-14, $4M), while other labels (Pre-Seed, Series A, Non-equity Assistance) show up once.
Are there outliers at the low end worth flagging for qualification and timing?
Yes. Stready’s Non-equity Assistance is $100K (2022-03-21), far below the next-smallest disclosed amounts like $1M for Leasi (2024-07-01) and Aviant (2023-06-06). That makes Stready the smallest disclosed deal in the table, and it may behave differently in outreach or investment-cycle expectations than the rest of the disclosed equity rounds.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.